4.6 Article

Functional Dissection of HOXD Cluster Genes in Regulation of Neuroblastoma Cell Proliferation and Differentiation

期刊

PLOS ONE
卷 7, 期 8, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0040728

关键词

-

资金

  1. National Institutes of Health [CA124982]
  2. Georgia Cancer Coalition Distinguished Scholar Award
  3. National Science Foundation of China [NSFC 81101905]
  4. National Natural Science Foundation of China [81172443]

向作者/读者索取更多资源

Retinoic acid (RA) can induce growth arrest and neuronal differentiation of neuroblastoma cells and has been used in clinic for treatment of neuroblastoma. It has been reported that RA induces the expression of several HOXD genes in human neuroblastoma cell lines, but their roles in RA action are largely unknown. The HOXD cluster contains nine genes (HOXD1, HOXD3, HOXD4, and HOXD8-13) that are positioned sequentially from 39 to 59, with HOXD1 at the 39 end and HOXD13 the 59 end. Here we show that all HOXD genes are induced by RA in the human neuroblastoma BE(2)-C cells, with the genes located at the 39 end being activated generally earlier than those positioned more 59 within the cluster. Individual induction of HOXD8, HOXD9, HOXD10 or HOXD12 is sufficient to induce both growth arrest and neuronal differentiation, which is associated with downregulation of cell cycle-promoting genes and upregulation of neuronal differentiation genes. However, induction of other HOXD genes either has no effect (HOXD1) or has partial effects (HOXD3, HOXD4, HOXD11 and HOXD13) on BE(2)-C cell proliferation or differentiation. We further show that knockdown of HOXD8 expression, but not that of HOXD9 expression, significantly inhibits the differentiation-inducing activity of RA. HOXD8 directly activates the transcription of HOXC9, a key effector of RA action in neuroblastoma cells. These findings highlight the distinct functions of HOXD genes in RA induction of neuroblastoma cell differentiation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Atf3 deficiency promotes genome instability and spontaneous tumorigenesis in mice

Z. Wang, Y. He, W. Deng, L. Lang, H. Yang, B. Jin, R. Kolhe, H-F Ding, J. Zhang, T. Hai, C. Yan

ONCOGENE (2018)

Article Oncology

Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation

Liqun Yang, Yunhong Zha, Jane Ding, Bingwei Ye, Mengling Liu, Chunhong Yan, Zheng Dong, Hongjuan Cui, Han-Fei Ding

ONCOGENESIS (2019)

Article Oncology

Metabolic Reprogramming by MYCN Confers Dependence on the Serine-Glycine-One-Carbon Biosynthetic Pathway

Yingfeng Xia, Bingwei Ye, Jane Ding, Yajie Yu, Ahmet Alptekin, Muthusamy Thangaraju, Puttur D. Prasad, Zhi-Chun Ding, Eun Jeong Park, Jeong-Hyeon Choi, Bei Gao, Oliver Fiehn, Chunhong Yan, Zheng Dong, Yunhong Zha, Han-Fei Ding

CANCER RESEARCH (2019)

Article Biochemistry & Molecular Biology

ATF3 promotes erastin-induced ferroptosis by suppressing system Xc-

Liyuan Wang, Yichen Liu, Tingting Du, Heng Yang, Lei Lei, Mengqi Guo, Han-Fei Ding, Junran Zhang, Hongbo Wang, Xiaoguang Chen, Chunhong Yan

CELL DEATH AND DIFFERENTIATION (2020)

Article Biochemistry & Molecular Biology

Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicity

Ahmet Alptekin, Bingwei Ye, Yajie Yu, Candace J. Poole, Jan van Riggelen, Yunhong Zha, Han-Fei Ding

ONCOGENE (2019)

Article Biochemistry & Molecular Biology

Competitive ubiquitination activates the tumor suppressor p53

Xingyao Li, Mengqi Guo, Lun Cai, Tingting Du, Ying Liu, Han-Fei Ding, Hongbo Wang, Junran Zhang, Xiaoguang Chen, Chunhong Yan

CELL DEATH AND DIFFERENTIATION (2020)

Article Oncology

PRMT1 promotes neuroblastoma cell survival through ATF5

Zhong-Yan Hua, Jeanne N. Hansen, Miao He, Shang-Kun Dai, Yoonjung Choi, Melody D. Fulton, Sarah M. Lloyd, Marianna Szemes, Ji Sen, Han-Fei Ding, James M. Angelastro, Xiang Fei, Hui-Ping Li, Chao-Ran Wu, Sheng-Yong Yang, Karim Malik, Xiaomin Bao, Y. George Zheng, Chang-Mei Liu, Nina F. Schor, Zhi-Jie Li, Xing-Guo Li

ONCOGENESIS (2020)

Article Medicine, Research & Experimental

p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease

Zhengwei Ma, Lin Li, N. J. Livingston, Dongshan Zhang, Qingsheng Mi, Ming Zhang, Han-Fei Ding, Yuqing Huo, Changlin Mei, Zheng Dong

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Cell Biology

Therapeutic targeting of both dihydroorotate dehydrogenase and nucleoside transport in MYCN-amplified neuroblastoma

Yajie Yu, Jane Ding, Shunqin Zhu, Ahmet Alptekin, Zheng Dong, Chunhong Yan, Yunhong Zha, Han-Fei Ding

Summary: Metabolic reprogramming driven by oncogenes like MYC is closely related to growth promotion, but also leads to potential therapeutic metabolic dependencies; MYCN-amplified neuroblastoma promotes pyrimidine nucleotide production by upregulating DHODH and other enzymes, and inhibition of DHODH can effectively suppress proliferation and tumorigenicity of these cancer cells.

CELL DEATH & DISEASE (2021)

Article Cell Biology

ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction

Xingyao Li, Daniel Gracilla, Lun Cai, Mingyi Zhang, Xiaolin Yu, Xiaoguang Chen, Junran Zhang, Xiaochun Long, Han-Fei Ding, Chunhong Yan

Summary: ATF3 plays a crucial role in transcriptional activation of the serine synthesis pathway (SSP) under serine deprivation, positively correlates with PHGDH expression, and loss of ATF3 expression impairs cancer cell growth.

CELL REPORTS (2021)

Article Pathology

Single-Nucleus Transcriptional Profiling of Chronic Kidney Disease after Cisplatin Nephrotoxicity

Zhengwei Ma, Xiaoru Hu, Han-Fei Ding, Ming Zhang, Yuqing Huo, Zheng Dong

Summary: This study is the first to investigate cisplatin-induced nephrotoxicity using snRNA-seq, revealing that RLDC treatment leads to renal dysfunction and pathological changes in mice, as well as transcriptional alterations at the single-cell level in PT cells.

AMERICAN JOURNAL OF PATHOLOGY (2022)

Article Oncology

G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes

Chunwan Lu, Dafeng Yang, John D. Klement, Yolonda L. Colson, Nicholas H. Oberlies, Cedric J. Pearce, Aaron H. Colby, Mark W. Grinstaff, Han-Fei Ding, Huidong Shi, Kebin Liu

Summary: This study reveals the impact of metabolic pathways on the function of tumor-specific CTLs and tumor immune evasion. It identifies the key role of G6PD in CTL activation and discovers the significance of the H3K9me3/G6PD/acetyl-CoA/H3K9ac/Gzmb pathway in epithelioid mesothelioma.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Biochemistry & Molecular Biology

H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth

Chunwan Lu, Dafeng Yang, John D. Klement, Yolonda L. Colson, Nicholas H. Oberlies, Cedric J. Pearce, Aaron H. Colby, Mark W. Grinstaff, Zhuoqi Liu, Huidong Shi, Han-Fei Ding, Kebin Liu

Summary: The role of G6PD in human cancer is not fully understood. Inhibition of H3K9 methylation suppresses aerobic glycolysis and enhances PPP, leading to increased tumor cell apoptosis. Activation of G6PD induces tumor cell death, suppresses tumor growth, and increases mouse survival in vivo.

ONCOGENE (2022)

Article Oncology

A Negative Regulatory Role for RKIP in Breast Cancer Immune Response

Vu N. Bach, Jane Ding, Miranda Yeung, Taylor Conrad, Hussain N. Odeh, Paige Cubberly, Christopher Figy, Han-Fei Ding, Robert Trumbly, Kam C. Yeung

Summary: Breast cancer is the second most common cancer in women worldwide, and the regulation of its metastasis is not well understood. RKIP has been shown to suppress breast cancer metastasis by downregulating elements of the immune system. In addition to its negative regulation of the Raf signaling pathway, RKIP may exert its effects on cancer through modulating various signaling pathways, including those involved in immune response.

CANCERS (2022)

Review Oncology

MYCN and Metabolic Reprogramming in Neuroblastoma

Mohit Bansal, Anamika Gupta, Han-Fei Ding

Summary: Metabolic reprogramming plays a crucial role in high-risk neuroblastoma and offers potential therapeutic opportunities. This review summarizes the recent progress in understanding neuroblastoma metabolic reprogramming and highlights important areas for future research.

CANCERS (2022)

暂无数据